These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21270909)

  • 1. Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes. Consensus document.
    Menéndez Torre E; Lafita Tejedor J; Artola Menéndez S; Milán Núñez-Cortés J; Alonso García A; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R; ; ; ; ; ; ; ; ; ;
    Nefrologia; 2011; 31(1):17-26. PubMed ID: 21270909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].
    Menéndez Torre E; Lafita Tejedor J; Artola Menéndez S; Millán Núñez-Cortés J; Alonso García A; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R;
    Rev Clin Esp; 2011 Mar; 211(3):147-55. PubMed ID: 21376312
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].
    Menéndez Torre E; Lafita Tejedor FJ; Artola Menéndez S; Millán Núñez-Cortés J; Alonso García Á; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R;
    Endocrinol Nutr; 2011 Mar; 58(3):112-20. PubMed ID: 21354873
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].
    Menéndez Torre E; Lafita Tejedor FJ; Artola Menéndez S; Millán Núñez-Cortés J; Alonso García A; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R;
    Aten Primaria; 2011 Apr; 43(4):202.e1-9. PubMed ID: 21382648
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment guidelines for hyperglycaemia in type 2 diabetes patients with stable chronic heart failure or ischemic cardiomyopathy without heart failure].
    Alonso-García A; García-Soidán FJ; Lisbona-Gil A
    Med Clin (Barc); 2010 May; 134(13):596-9. PubMed ID: 20303545
    [No Abstract]   [Full Text] [Related]  

  • 6. Metformin added to insulin therapy in poorly controlled type 2 diabetes.
    Hirsch IB
    Diabetes Care; 1999 May; 22(5):854. PubMed ID: 10332695
    [No Abstract]   [Full Text] [Related]  

  • 7. When metformin fails in type 2 diabetes mellitus.
    Esposito K; Bellastella G; Giugliano D
    Arch Intern Med; 2011 Feb; 171(4):365-6. PubMed ID: 21357815
    [No Abstract]   [Full Text] [Related]  

  • 8. Metformin useful in combination with exogenous insulin.
    Hanuschak LN
    Diabetes Care; 1996 Jun; 19(6):671-2. PubMed ID: 8725873
    [No Abstract]   [Full Text] [Related]  

  • 9. Using the respective contributions of postprandial and basal glucose for tailoring treatments in type 2 diabetes.
    Monnier L; Colette C
    Diabetes Metab; 2015 Jun; 41(3):179-82. PubMed ID: 25900889
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin as initial therapy for type 2 diabetes is not in the patient's best interest.
    Bell DS
    Endocr Pract; 2004; 10(3):208-12. PubMed ID: 15310539
    [No Abstract]   [Full Text] [Related]  

  • 11. Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update.
    Gomez-Peralta F; Escalada San Martín FJ; Menéndez Torre E; Mata Cases M; Ferrer García JC; Ezkurra Loiola P; Ávila Lachica L; Fornos Pérez JA; Artola Menéndez S; Álvarez-Guisasola F; Rica Echevarría I; Girbés Borrás J;
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):611-624. PubMed ID: 30366843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of metformin in type II diabetes.
    Epstein S
    Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing hyperglycaemia.
    Curtis S
    Br J Gen Pract; 2008 Oct; 58(555):729; authore reply 729-30. PubMed ID: 18826786
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperglycaemia in inpatients with type 2 diabetes mellitus.
    Mohan S; Fenton DR; Solomon A; de Wolff JF
    Br J Hosp Med (Lond); 2012 Aug; 73(8):C124-8. PubMed ID: 22875479
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
    Vos RC; Rutten GEHM
    JAMA; 2017 Oct; 318(15):1489-1490. PubMed ID: 29049639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes: insulin plus metformin for T2DM--are there benefits?
    Bailey CJ
    Nat Rev Endocrinol; 2012 Jun; 8(8):449-50. PubMed ID: 22733270
    [No Abstract]   [Full Text] [Related]  

  • 17. Hot Topics in Primary Care: Titratable Fixed-Ratio Combinations in Type 2 Diabetes Mellitus: Focus on GLP-1R Agonists Combined With Basal Insulin.
    LaSalle J; White JR
    J Fam Pract; 2017 Apr; 66(4 Suppl):S28-S33. PubMed ID: 28375405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illustrative case and discussion: a 58-year-old man with diabetes.
    Freeman JS
    J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS25-7. PubMed ID: 20644203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical treatment of type 2 diabetes. Recommendations for good practice].
    Diabetes Metab; 2007 Jan; 33(1 Pt 2):1S26-105. PubMed ID: 17499188
    [No Abstract]   [Full Text] [Related]  

  • 20. Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes.
    Otsuka Y; Yamaguchi S; Furukawa A; Kosuda M; Nakazaki M; Ishihara H
    Endocr J; 2015; 62(2):133-43. PubMed ID: 25328079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.